May Cho

Title(s)Assistant Professor, Internal Medicine
SchoolUniversity of California, Davis
AddressCancer Center, 4501 X Street, #3016
CA 95817
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma. Int J Mol Sci. 2020 Jul 23; 21(15). Gong J, Chuang J, Cho M, Toomey K, Hendifar A, Li D. PMID: 32718047.
      View in: PubMed   Mentions:    Fields:    
    2. Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series. J Natl Compr Canc Netw. 2020 Jul; 18(7):798-804. Demisse R, Damle N, Kim E, Gong J, Fakih M, Eng C, Oesterich L, McKenny M, Ji J, Liu J, Louie R, Tam K, Gholami S, Halabi W, Monjazeb A, Dayyani F, Cho M. PMID: 32634770.
      View in: PubMed   Mentions:    Fields:    
    3. Recent Advances in Targeted Therapies for Advanced Gastrointestinal Malignancies. Cancers (Basel). 2020 May 06; 12(5). Huynh JC, Schwab E, Ji J, Kim E, Joseph A, Hendifar A, Cho M, Gong J. PMID: 32384640.
      View in: PubMed   Mentions:
    4. The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report. Front Oncol. 2020; 10:581. Judge SJ, Ji J, Liu J, Kaur M, Kim E, Gong J, Tam KW, Kirane AR, Gholami S, Canter RJ, Bold RJ, Gangi A, Fakih M, Cho M. PMID: 32373540.
      View in: PubMed   Mentions:
    5. Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy. Mol Cancer Ther. 2020 04; 19(4):1070-1079. Zimmermann M, Li T, Semrad TJ, Wu CY, Yu A, Cimino G, Malfatti M, Haack K, Turteltaub KW, Pan CX, Cho M, Kim EJ, Henderson PT. PMID: 32029633.
      View in: PubMed   Mentions:    Fields:    
    6. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):e372-e377. Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. PMID: 31866577.
      View in: PubMed   Mentions:    Fields:    
    7. Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. J Clin Invest. 2019 10 01; 129(10):4464-4476. Fakih M, Ouyang C, Wang C, Tu TY, Gozo MC, Cho M, Sy M, Longmate JA, Lee PP. PMID: 31524634.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    8. Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clin Colorectal Cancer. 2019 12; 18(4):307-309. Gong J, Robertson MD, Kim E, Fakih M, Schrock AB, Tam KW, Burugapalli B, Monjazeb AM, Hendifar AE, Hitchins M, Klempner SJ, Cho M. PMID: 31563511.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. PD-1 Blockade in a Liver Transplant Recipient With Microsatellite Unstable Metastatic Colorectal Cancer and Hepatic Impairment. J Natl Compr Canc Netw. 2019 09 01; 17(9):1026-1030. Chen JA, Esteghamat N, Kim EJ, Garcia G, Gong J, Fakih MG, Bold RJ, Cho MT. PMID: 31487676.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Ann Oncol. 2019 07 01; 30(7):1096-1103. Schrock AB, Ouyang C, Sandhu J, Sokol E, Jin D, Ross JS, Miller VA, Lim D, Amanam I, Chao J, Catenacci D, Cho M, Braiteh F, Klempner SJ, Ali SM, Fakih M. PMID: 31038663.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    11. Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life. Cancers (Basel). 2019 Jun 18; 11(6). Li D, Sedano S, Allen R, Gong J, Cho M, Sharma S. PMID: 31216701.
      View in: PubMed   Mentions:
    12. A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction. Oncologist. 2019 08; 24(8):1137-1145. Gong J, Cho M, Gupta R, Synold TW, Frankel P, Ruel C, Fakih M, Chung V, Lim D, Chao J. PMID: 30710067.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    13. Capecitabine-induced hypertriglyceridemia: a rare but clinically relevant treatment-related adverse event. J Gastrointest Oncol. 2018 Dec; 9(6):1213-1219. Uche A, Vankina R, Gong J, Cho M, Yeh JJ, Kim P, Pan K. PMID: 30603144.
      View in: PubMed   Mentions:
    14. Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade. Clin Transl Med. 2018 Oct 08; 7(1):32. Gong J, Hendifar A, Tuli R, Chuang J, Cho M, Chung V, Li D, Salgia R. PMID: 30294755.
      View in: PubMed   Mentions:
    15. A single institution experience with palbociclib toxicity requiring dose modifications. Breast Cancer Res Treat. 2018 Apr; 168(2):381-387. Gong J, Cho M, Yu KW, Waisman J, Yuan Y, Mortimer J. PMID: 29218462.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres® versus SIR-Spheres® alone in chemotherapy-resistant colorectal cancer liver metastases. J Gastrointest Oncol. 2017 Aug; 8(4):608-613. Cho M, Kessler J, Park JJ, Lee A, Gong J, Singh G, Chen YJ, Ituarte PHG, Fakih M. PMID: 28890809.
      View in: PubMed   Mentions:
    17. A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy. Oncotarget. 2017 Oct 03; 8(45):79750-79760. Cho M, Gong J, Frankel P, Synold TW, Lim D, Chung V, Chao J, Li D, Chen Y, Sentovich S, Melstrom K, Singh G, Luevanos E, Fakih M. PMID: 29108355.
      View in: PubMed   Mentions: 2     Fields:    
    18. Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience. Oncotarget. 2017 Jun 27; 8(26):42198-42213. Gong J, Cho M, Sy M, Salgia R, Fakih M. PMID: 28178681.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function. J Gastrointest Oncol. 2017 Apr; 8(2):314-323. Gong J, Cho M, Fakih M. PMID: 28480070.
      View in: PubMed   Mentions:
    20. RAS and BRAF in metastatic colorectal cancer management. J Gastrointest Oncol. 2016 Oct; 7(5):687-704. Gong J, Cho M, Fakih M. PMID: 27747083.
      View in: PubMed   Mentions:
    21. Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastases. World J Gastrointest Oncol. 2016 Jan 15; 8(1):128-35. Cho M, Akiba C, Lau C, Smith D, Telatar M, Afkhami M, Sentovich S, Melstrom K, Fakih M. PMID: 26798444.
      View in: PubMed   Mentions:
    22. The state of regional therapy in the management of metastatic colorectal cancer to the liver. Expert Rev Anticancer Ther. 2016; 16(2):229-45. Cho M, Gong J, Fakih M. PMID: 26652741.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    23. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma. HPB (Oxford). 2015 Jul; 17(7):587-93. Cho M, Wang-Gillam A, Myerson R, Gao F, Strasberg S, Picus J, Sorscher S, Fournier C, Nagaraj G, Parikh P, Suresh R, Linehan D, Tan BR. PMID: 25800066.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    24. Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma. J Gastrointest Oncol. 2013 Dec; 4(4):370-3. Peddi PF, Cho M, Wang J, Gao F, Wang-Gillam A. PMID: 24294508.
      View in: PubMed   Mentions:
    25. Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells. J Cancer. 2013; 4(8):671-8. Cho M, Kabir SM, Dong Y, Lee E, Rice VM, Khabele D, Son DS. PMID: 24155779.
      View in: PubMed   Mentions:
    26. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. J Transl Med. 2013 Sep 08; 11:206. Cho M, Peddi PF, Ding K, Chen L, Thomas D, Wang J, Lockhart AC, Tan B, Wang-Gillam A. PMID: 24011168.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    27. Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options. Hematology. 2012 Nov; 17(6):325-8. Dunn T, Cho M, Medeiros B, Logan A, Ungewickell A, Liedtke M. PMID: 23168071.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans